These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6685811)

  • 21. [Antibiotic prophylaxis with mezlocillin in elective biliary surgery].
    Colombo A; Perotti F; Landi G; Primatesta F; David PG; Landonio M
    Minerva Med; 1995 Apr; 86(4):167-9. PubMed ID: 7623973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of mezlocillin in treatment of acute and chronic prostatitis.
    Battista R; Corsetti G; Rondoni M; Lucchetti R
    J Chemother; 1989 Jul; 1(4 Suppl):871-2. PubMed ID: 16312679
    [No Abstract]   [Full Text] [Related]  

  • 23. A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.
    McCormick PA; Greenslade L; Kibbler CC; Chin JK; Burroughs AK; McIntyre N
    Hepatology; 1997 Apr; 25(4):833-6. PubMed ID: 9096584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of mezlocillin in combination with metronidazole in patients with perforation of the inflamed appendix.
    Kujath P; Rauh V; Weisser C; Hofmann G
    J Chemother; 1989 Jul; 1(4 Suppl):816-7. PubMed ID: 16312653
    [No Abstract]   [Full Text] [Related]  

  • 25. Inability of cytoplasmic or nuclear androgen receptor content or distribution to distinguish benign from carcinomatous human prostate.
    Shain SA; Gorelic LS; Klipper RW; Ramzy I; Novicki DE; Radwin HM; Lamm DL
    Cancer Res; 1983 Aug; 43(8):3691-5. PubMed ID: 6861139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cytostatic drug concentrations in the kidney, bladder wall, and prostate by means of the diffusion chamber technique in dogs.
    Porpaczy P; Schmidbauer CP; Georgopoulos A; Rameis H; Endler TA
    Urol Res; 1983; 11(5):215-21. PubMed ID: 6659213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Zinc levels in the normal and pathological prostatic tissue].
    Maganto Pavón E
    Actas Urol Esp; 1980; 4(1):15-20. PubMed ID: 7361597
    [No Abstract]   [Full Text] [Related]  

  • 30. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefepime for infections of the biliary tract.
    Thompson JE; Bennion RS; Roettger R; Lally KP; Hopkins JA; Wilson SE
    Surg Gynecol Obstet; 1993; 177 Suppl():30-4; discussion 35-40. PubMed ID: 8256189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic mezlocillin in vaginal hysterectomy: a prospective, randomized study.
    Conturso R; Radaelli L; Turtulici P; Alegente G; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):1033-4. PubMed ID: 16312759
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis and therapy by mezlocillin in pediatric surgery.
    Di Benedetto A; Abela M; Sanges G; Randazzo G; Bagnara V; Di Benedetto AG; Cacciaguerra S; Vasta G; Speciale A; Caccamo F; Nicoletti G
    J Chemother; 1989 Jul; 1(4 Suppl):1065-8. PubMed ID: 16312774
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic data and therapeutic efficacy of miocamycin: serum, urinary and prostatic levels. Therapeutic aspects in acute urethral syndrome and non-gonococcal urethritis.
    Furneri PM; Roccasalva L; Fallica L; Tempera G
    J Chemother; 1989 Jul; 1(4 Suppl):581-2. PubMed ID: 16312542
    [No Abstract]   [Full Text] [Related]  

  • 36. Mezlocillin versus cefotetan in abdominal hysterectomy prophylaxis: a prospective randomized study. Preliminary results.
    Conturso R; Bucciero A; Marcolli R; Alegente G; Regallo M; Tagliabue R; Molteni E; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):1035-7. PubMed ID: 16312760
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylactic mezlocillin-netilmicin combination in pacemaker surgery: a prospective, randomized study.
    Bonini W; Broffoni T; Fiorista F; Brambilla G; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):1060-1. PubMed ID: 16312771
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of mezlocillin and cefotetan in cesarean section prophylaxis: a prospective, randomized study. Preliminary results.
    Ognissanti F; Bucciero A; Conturso R; Bonifacino G; Tagliabue R; Molteni E; Lovotti M; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):1030-2. PubMed ID: 16312758
    [No Abstract]   [Full Text] [Related]  

  • 39. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
    Sabichi AL; Lee JJ; Taylor RJ; Thompson IM; Miles BJ; Tangen CM; Minasian LM; Pisters LL; Caton JR; Basler JW; Lerner SP; Menter DG; Marshall JR; Crawford ED; Lippman SM
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2178-84. PubMed ID: 16609032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shift of the f/t-PSA quotient in relation to renal insufficiency: consequences for the early detection of prostate carcinoma in patients with terminal renal failure.
    Fischer K; Hamza A; Wicht A; Loertzer H; Fornara P
    Anticancer Res; 2007; 27(4A):1945-8. PubMed ID: 17649801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.